• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
 
Generic Name:  leukocyte interleukin
Trade Name:  Multikine
Date Designated:  05/04/2007
Orphan Designation:  Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
CEL-SCI Corporation
8229 Boone Blvd.
Suite 802
Vienna, Virginia 22182

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-